Background/Aim: Hepatocellular carcinoma (HCC) mainly develops in the damaged liver
from hepatitis C virus (HCV) or hepatitis B virus (HBV) infection in Japan. On the other hand …

Background Alpha-fetoprotein (AFP) and des-γ-carboxy prothrombin (DCP) are well-known
tumor markers of hepatocellular carcinoma (HCC). The aims of this study are to calculate the …

Alpha‐fetoprotein (AFP) and des‐γ‐carboxy prothrombin (DCP) are widely used
complementary tumor markers for hepatocellular carcinoma (HCC). In this study, we …

AIM: To clarify the utility of using des-γ-carboxy prothrombin (DCP) and α-fetoprotein (AFP)
levels to predict the prognosis of hepatocellular carcinoma (HCC) in patients with hepatitis B …

Objective: To determine the diagnostic value of alpha-fetoprotein (AFP) and des-gamma-
carboxy prothrombin (DCP) for patients with non-B, non-C hepatocellular carcinoma (NBNC …

BACKGROUND The aim of this study was to elucidate the usefulness of measuring the
positive status of both des‐γ‐carboxy prothrombin (DCP) and α‐fetoprotein (AFP) …

Background The importance of alpha-fetoprotein (AFP) and des-gamma-
carboxyprothrombin (DCP) in hepatocellular carcinoma (HCC) has been studied extensively …

Background The utility of pre-and post-operative alpha-fetoprotein (AFP) and des-gamma (γ)-
carboxy prothrombin (DCP) expression patterns and their dynamic changes as predictors of …

We evaluated the clinical value of perioperative α-fetoprotein (AFP) and des-γ-carboxy
prothrombin (DCP) levels in predicting recurrence of hepatocellular carcinoma (HCC) after …

BACKGROUND Alpha-fetoprotein (AFP), a commonly used biomarker for hepatocellular
carcinoma (HCC), is normal in up to one-third of patients. AIM To evaluate the diagnostic …